Filed: 8/13/2025ACC: 0001104659-25-077492
📋 What this filing means
DECHENG CAPITAL LLC filed this quarterly 13F‑HR report disclosing 25 equity positions with a total reported market value of $395.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
25
Positions
$395.97M
Total AUM (reported)
58.58M
Total Shares
Allocation by class
COM$384.48M97.1%
SHS$10.65M2.7%
ADR$709.8K0.2%
WARRANTS$127.3K0.0%
Portfolio Concentration
Top 3$269.24M68.0%
4–10$96.57M24.4%
11–25$30.16M7.6%
Top 3 weight
68.0%
Top 10 weight
92.4%
Voting Authority Distribution
Total shares with voting rights: 58.58M
Sole
Full voting authority
58.58M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole25
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings25
Rows:
CG ONCOLOGY INC
SOLEShares6.37M
TypeSH
Market value$165.66M
41.84%
Sole
6.37M
Shared
0.00
None
0.00
AARDVARK THERAPEUTICS INC
SOLEShares3.92M
TypeSH
Market value$52.96M
13.38%
Sole
3.92M
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares25.95M
TypeSH
Market value$50.61M
12.78%
Sole
25.95M
Shared
0.00
None
0.00
Upstream Bio Inc.
SOLEShares3.29M
TypeSH
Market value$36.07M
9.11%
Sole
3.29M
Shared
0.00
None
0.00
NEWAMSTERDAM PHARMA CO NV
SOLEShares770K
TypeSH
Market value$13.94M
3.52%
Sole
770K
Shared
0.00
None
0.00
BeyondSpring Inc.
SOLEShares4.53M
TypeSH
Market value$10.65M
2.69%
Sole
4.53M
Shared
0.00
None
0.00
MERUS NV
SOLEShares189.10K
TypeSH
Market value$9.95M
2.51%
Sole
189.10K
Shared
0.00
None
0.00
KRYSTAL BIOTECH INC
SOLEShares66K
TypeSH
Market value$9.07M
2.29%
Sole
66K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares181.60K
TypeSH
Market value$8.57M
2.16%
Sole
181.60K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC(NSM)
SOLEShares226K
TypeSH
Market value$8.31M
2.10%
Sole
226K
Shared
0.00
None
0.00
Aclaris Therapeutics, Inc.
SOLEShares4.04M
TypeSH
Market value$5.74M
1.45%
Sole
4.04M
Shared
0.00
None
0.00
Lyell Immunopharma, Inc.
SOLEShares595.47K
TypeSH
Market value$5.26M
1.33%
Sole
595.47K
Shared
0.00
None
0.00
ARCELLX INC
SOLEShares547.61K
TypeSH
Market value$4.46M
1.13%
Sole
547.61K
Shared
0.00
None
0.00
CRINETICS PHARMACEUTICALS IN
SOLEShares143K
TypeSH
Market value$4.11M
1.04%
Sole
143K
Shared
0.00
None
0.00
Aura Biosciences, Inc.
SOLEShares515.55K
TypeSH
Market value$3.23M
0.82%
Sole
515.55K
Shared
0.00
None
0.00
Zentalis Pharmaceuticals Inc.
SOLEShares1.32M
TypeSH
Market value$1.54M
0.39%
Sole
1.32M
Shared
0.00
None
0.00
Equillium Inc.
SOLEShares4.45M
TypeSH
Market value$1.40M
0.35%
Sole
4.45M
Shared
0.00
None
0.00
4D MOLECULAR THERAPEUTICS IN
SOLEShares239.51K
TypeSH
Market value$888.6K
0.22%
Sole
239.51K
Shared
0.00
None
0.00
Arcus Biosciences, Inc
SOLEShares160K
TypeSH
Market value$811.2K
0.20%
Sole
160K
Shared
0.00
None
0.00
Illumnia, Inc.
SOLEShares7.98K
TypeSH
Market value$761.3K
0.19%
Sole
7.98K
Shared
0.00
None
0.00
LEGEND BIOTECH CORP-ADR
SOLEShares20K
TypeSH
Market value$709.8K
0.18%
Sole
20K
Shared
0.00
None
0.00
GRAIL INC
SOLEShares9.68K
TypeSH
Market value$498.0K
0.13%
Sole
9.68K
Shared
0.00
None
0.00
Pyxis Oncology, Inc (formerly Apexigen)
SOLEShares326.81K
TypeSH
Market value$359.5K
0.09%
Sole
326.81K
Shared
0.00
None
0.00
REZOLUTE INC
SOLEShares59.90K
TypeSH
Market value$267.2K
0.07%
Sole
59.90K
Shared
0.00
None
0.00
Nuvation Bio Inc.
SOLEShares646.06K
TypeSH
Market value$127.3K
0.03%
Sole
646.06K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CG ONCOLOGY INCSOLE | COM | 6.37M | SH | $165.66M 41.84% | 6.37M | 0.00 | 0.00 |
AARDVARK THERAPEUTICS INCSOLE | COM | 3.92M | SH | $52.96M 13.38% | 3.92M | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | COM | 25.95M | SH | $50.61M 12.78% | 25.95M | 0.00 | 0.00 |
Upstream Bio Inc.SOLE | COM | 3.29M | SH | $36.07M 9.11% | 3.29M | 0.00 | 0.00 |
NEWAMSTERDAM PHARMA CO NVSOLE | COM | 770K | SH | $13.94M 3.52% | 770K | 0.00 | 0.00 |
BeyondSpring Inc.SOLE | SHS | 4.53M | SH | $10.65M 2.69% | 4.53M | 0.00 | 0.00 |
MERUS NVSOLE | COM | 189.10K | SH | $9.95M 2.51% | 189.10K | 0.00 | 0.00 |
KRYSTAL BIOTECH INCSOLE | COM | 66K | SH | $9.07M 2.29% | 66K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | COM | 181.60K | SH | $8.57M 2.16% | 181.60K | 0.00 | 0.00 |
REVOLUTION MEDICINES INC(NSM)SOLE | COM | 226K | SH | $8.31M 2.10% | 226K | 0.00 | 0.00 |
Aclaris Therapeutics, Inc.SOLE | COM | 4.04M | SH | $5.74M 1.45% | 4.04M | 0.00 | 0.00 |
Lyell Immunopharma, Inc.SOLE | COM | 595.47K | SH | $5.26M 1.33% | 595.47K | 0.00 | 0.00 |
ARCELLX INCSOLE | COM | 547.61K | SH | $4.46M 1.13% | 547.61K | 0.00 | 0.00 |
CRINETICS PHARMACEUTICALS INSOLE | COM | 143K | SH | $4.11M 1.04% | 143K | 0.00 | 0.00 |
Aura Biosciences, Inc.SOLE | COM | 515.55K | SH | $3.23M 0.82% | 515.55K | 0.00 | 0.00 |
Zentalis Pharmaceuticals Inc.SOLE | COM | 1.32M | SH | $1.54M 0.39% | 1.32M | 0.00 | 0.00 |
Equillium Inc.SOLE | COM | 4.45M | SH | $1.40M 0.35% | 4.45M | 0.00 | 0.00 |
4D MOLECULAR THERAPEUTICS INSOLE | COM | 239.51K | SH | $888.6K 0.22% | 239.51K | 0.00 | 0.00 |
Arcus Biosciences, IncSOLE | COM | 160K | SH | $811.2K 0.20% | 160K | 0.00 | 0.00 |
Illumnia, Inc.SOLE | COM | 7.98K | SH | $761.3K 0.19% | 7.98K | 0.00 | 0.00 |
LEGEND BIOTECH CORP-ADRSOLE | ADR | 20K | SH | $709.8K 0.18% | 20K | 0.00 | 0.00 |
GRAIL INCSOLE | COM | 9.68K | SH | $498.0K 0.13% | 9.68K | 0.00 | 0.00 |
Pyxis Oncology, Inc (formerly Apexigen)SOLE | COM | 326.81K | SH | $359.5K 0.09% | 326.81K | 0.00 | 0.00 |
REZOLUTE INCSOLE | COM | 59.90K | SH | $267.2K 0.07% | 59.90K | 0.00 | 0.00 |
Nuvation Bio Inc.SOLE | WARRANTS | 646.06K | SH | $127.3K 0.03% | 646.06K | 0.00 | 0.00 |